Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
J Acquir Immune Defic Syndr ; 77(1): 102-109, 2018 01 01.
Artículo en Inglés | MEDLINE | ID: mdl-28991888

RESUMEN

BACKGROUND: The differential effects of commonly prescribed combined antiretroviral therapy (cART) regimens on AIDS-defining neurological conditions (neuroAIDS) remain unknown. SETTING: Prospective cohort studies of HIV-positive individuals from Europe and the Americas included in the HIV-CAUSAL Collaboration. METHODS: Individuals who initiated a first-line cART regimen in 2004 or later containing a nucleoside reverse transcriptase inhibitor backbone and either atazanavir, lopinavir, darunavir, or efavirenz were followed from cART initiation until death, lost to follow-up, pregnancy, the cohort-specific administrative end of follow-up, or the event of interest, whichever occurred earliest. We evaluated 4 neuroAIDS conditions: HIV dementia and the opportunistic infections toxoplasmosis, cryptococcal meningitis, and progressive multifocal leukoencephalopathy. For each outcome, we estimated hazard ratios for atazanavir, lopinavir, and darunavir compared with efavirenz via a pooled logistic model. Our models were adjusted for baseline demographic and clinical characteristics. RESULTS: Twenty six thousand one hundred seventy-two individuals initiated efavirenz, 5858 initiated atazanavir, 8479 initiated lopinavir, and 4799 initiated darunavir. Compared with efavirenz, the adjusted HIV dementia hazard ratios (95% confidence intervals) were 1.72 (1.00 to 2.96) for atazanavir, 2.21 (1.38 to 3.54) for lopinavir, and 1.41 (0.61 to 3.24) for darunavir. The respective hazard ratios (95% confidence intervals) for the combined end point were 1.18 (0.74 to 1.88) for atazanavir, 1.61 (1.14 to 2.27) for lopinavir, and 1.36 (0.74 to 2.48) for darunavir. The results varied in subsets defined by calendar year, nucleoside reverse transcriptase inhibitor backbone, and age. CONCLUSION: Our results are consistent with an increased risk of neuroAIDS after initiating lopinavir compared with efavirenz, but temporal changes in prescribing trends and confounding by indication could explain our findings.


Asunto(s)
Complejo SIDA Demencia/epidemiología , Infecciones Oportunistas Relacionadas con el SIDA/epidemiología , Síndrome de Inmunodeficiencia Adquirida/tratamiento farmacológico , Leucoencefalopatía Multifocal Progresiva/epidemiología , Meningitis Criptocócica/epidemiología , Toxoplasmosis/epidemiología , Adulto , Alquinos , Américas/epidemiología , Sulfato de Atazanavir/uso terapéutico , Benzoxazinas/uso terapéutico , Estudios de Cohortes , Ciclopropanos , Darunavir/uso terapéutico , Europa (Continente)/epidemiología , Femenino , Inhibidores de la Proteasa del VIH/uso terapéutico , Humanos , Lopinavir/uso terapéutico , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Inhibidores de la Transcriptasa Inversa/uso terapéutico
2.
Rev. latinoam. enferm ; 18(3): 373-380, May-June 2010. tab
Artículo en Inglés, Español, Portugués | LILACS, BDENF - Enfermería | ID: lil-554467

RESUMEN

This research aimed to identify the determinants of full breastfeeding (FBF) and any breastfeeding (ABF) cessation before 6 months, through a six-month follow-up of 248 mothers going a postpartum visit. Data were collected by personal interview during the first month and telephone interviews at four and six months postpartum. Cox’s proportional hazards model was used. Not having previous ABF experience, previous ABF duration ≤4 months and worse evaluation of previous experience were associated with cessation of ABF and FBF. Lower educational level was associated with cessation of ABF and the use of pacifiers or occasional breast-milk substitutes with cessation of FBF. Attending childbirth education was a protective factor against early FBF or ABF cessation. Activities supporting breastfeeding should be intensified for mothers with poorer access to information and with negative or without ABF previous experience. The use of pacifiers and not-medically indicated breast milk substitutes should be controlled.


O objetivo da pesquisa foi identificar os fatores associados ao abandono do aleitamento materno (AM) e do aleitamento materno completo (AMC). Foram acompanhadas 248 mães que fizeram visita pós-parto. Os dados foram coletados mediante entrevista pessoal durante o primeiro mês pós-parto e, pelo telefone, aos quatro e seis meses seguintes. A análise se realizou mediante a Regressão de Cox. Os resultados mostram associação entre o abandono da AMC e do AM com o fato de não se ter amamentado anteriormente, com AM anterior ≤4 meses, e, com pior avaliação da experiência anterior. O menor nível de estudos se relaciona com maior abandono do AM e das chupetas, ou suplementos no hospital com o abandono da AMC. A educação pré-natal é fator protetor para o AMC e o AM. Conclui-se que o apoio ao AM deveria intensificar-se nas mães: sem experiência anterior, com experiência negativa, e, com pior acesso à informação; também deveria ser controlado o uso da chupeta e dos suplementos de leite artificial (LA) não indicados.


El objetivo de la investigación fue identificar los factores asociados al abandono de la lactancia materna (LM) y de la lactancia materna completa (LMC). Fueron acompañadas 248 madres que acudieron a la visita posparto. Los datos fueron recolectados mediante entrevista personal durante el primer mes posparto y por teléfono a los cuatro y seis meses siguientes. El análisis se realizó mediante la Regresión de Cox. Los resultados muestran una asociación con el abandono de la LMC y de la LM con no haber amamantado anteriormente, con LM anterior ≤4 meses, y, con una peor valoración de la experiencia anterior. El menor nivel de estudios se relaciona con un mayor abandono de la LM y los chupetes o suplementos en el hospital con el abandono de la LMC. La educación prenatal es un factor protector para la LMC y la LM. Se concluye que el apoyo a la LM debería intensificarse las madres: sin experiencia anterior, con experiencia negativa, y, con peor acceso a la información; también debería controlarse el uso de chupetes y suplementos de leche artificial (LA) no indicados.


Asunto(s)
Humanos , Lactante , Recién Nacido , Lactancia Materna/estadística & datos numéricos , Análisis Multivariante , Factores Socioeconómicos , Factores de Tiempo
3.
Int J Epidemiol ; 37(2): 329-40, 2008 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-18245151

RESUMEN

BACKGROUND: Among potential environmental risk factors for Alzheimer disease (AD), occupational exposures have received some attention, including extremely low frequency electromagnetic fields (ELF-EMF). A systematic review and meta-analysis of published epidemiological studies on this subject was carried out. METHODS: The search was concluded in April 2006. Bibliographic databases consulted included PubMed, EMBASE, Cochrane Library and NIOSHTIC2. Pooled estimates were obtained using random-effects meta-analysis. Sources of heterogeneity between studies were explored, as was publication bias. RESULTS: Fourteen different studies (nine case-control and five cohort studies) accomplished inclusion criteria. All these studies followed standardized criteria for AD diagnosis and most of them obtained quantitative estimates of exposure. Pooled estimates suggest an increased risk of AD from case-control studies (OR(pooled) 2.03; 95% CI 1.38-3.00) and from cohort studies (RR(pooled) 1.62; 95% CI 1.16-2.27), with moderate to high statistical heterogeneity in both cases (respectively, I(2) = 58% and I(2) = 54%). Cohort studies showed consistently increased risks for exposed men (RR(pooled) 2.05; 95% CI 1.51-2.80, I(2) = 0%). Evidence of dose-response relationship was not present. Test for publication bias suggests small study effects, mostly for case-control studies. CONCLUSIONS: Available epidemiological evidence suggests an association between occupational exposure to ELF-EMF and AD. However, some limitations affecting the results from this meta-analysis should be considered. More information on relevant duration and time windows of exposure, on biological mechanisms for this potential association and on interactions between electromagnetic fields exposure and established risk factors for AD is needed.


Asunto(s)
Enfermedad de Alzheimer/etiología , Campos Electromagnéticos/efectos adversos , Exposición Profesional/efectos adversos , Enfermedad de Alzheimer/epidemiología , Estudios de Casos y Controles , Estudios de Cohortes , Factores de Confusión Epidemiológicos , Humanos , Sesgo de Publicación , Riesgo , Tamaño de la Muestra
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA